{"transactions":[{"id":2357009,"issuer":{"id":4451,"kind":"organization","name":"Pediatrix Medical Group, Inc.","symbol":"MD"},"owners":[{"id":129660,"kind":"person","name":"Hinson Roger Mack","position":1,"cik":"0001826596","reported_name":"Hinson Roger Mack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres., PDX & OBX Medical Group"}}],"security":"Common Stock","published_at":"2022-03-03T22:01:09.000Z","date":"2022-03-01","kind":"tax_withholding","acquired":false,"shares":10244,"price":23.47,"value":240426.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents 10,244 restricted shares withheld for payment of taxes upon vesting of shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 12,246 restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan in connection with achievement in excess of target of specified performance-based criteria for the performance period from January 1, 2021 through December 31, 2021.  Also includes 64 shares acquired by reporting person through Issuer's Employee Stock Purchase Plan since the last Form 4 filing."}],"balance_after":109457,"source":{"system":"sec-edgar","filing":"0001209191-22-015591","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/893949/000120919122015591/doc4.xml","form_type":"4"}},{"id":2518511,"issuer":{"id":4451,"kind":"organization","name":"Pediatrix Medical Group, Inc.","symbol":"MD"},"owners":[{"id":129660,"kind":"person","name":"Hinson Roger Mack","position":1,"cik":"0001826596","reported_name":"Hinson Roger Mack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres., PDX & OBX Medical Group"}}],"security":"Common Stock","published_at":"2021-11-10T21:07:34.000Z","date":"2021-11-10","kind":"sale","acquired":false,"shares":8800,"price":28.38,"value":249744.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sales made pursuant to reporting person's 10b5-1 trading plan adopted June 15, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from\n$28.13 to $28.55 for a weighted average sales price of $28.38. The reporting person undertakes to provide the issuer, any security holder of the\nissuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each\nseparate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 62 shares acquired by reporting person through Issuer's Employee Stock Purchase Plan since the last Form 4 filing."}],"balance_after":107391,"source":{"system":"sec-edgar","filing":"0001209191-21-063836","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/893949/000120919121063836/doc4.xml","form_type":"4"}},{"id":2607569,"issuer":{"id":4451,"kind":"organization","name":"Pediatrix Medical Group, Inc.","symbol":"MD"},"owners":[{"id":129660,"kind":"person","name":"Hinson Roger Mack","position":1,"cik":"0001826596","reported_name":"Hinson Roger Mack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres., PDX & OBX Medical Group"}}],"security":"Common Stock","published_at":"2021-08-11T21:01:11.000Z","date":"2021-08-10","kind":"sale","acquired":false,"shares":8799,"price":32.35,"value":284647.65,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sales made pursuant to reporting person's 10b5-1 trading plan adopted June 15, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in thirty-six (36) separate transactions with prices ranging from $32.01 to $32.67 for an average weighted sale price of $32.35.  The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 128 shares acquired by the Reporting person through the Issuer's Employee Stock Purchase Plan since the last Form 4 filing."}],"balance_after":116129,"source":{"system":"sec-edgar","filing":"0001209191-21-050907","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/893949/000120919121050907/doc4.xml","form_type":"4"}},{"id":2816427,"issuer":{"id":4451,"kind":"organization","name":"Pediatrix Medical Group, Inc.","symbol":"MD"},"owners":[{"id":129660,"kind":"person","name":"Hinson Roger Mack","position":1,"cik":"0001826596","reported_name":"Hinson Roger Mack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres., PDX & OBX Medical Group"}}],"security":"Common Stock","published_at":"2021-03-03T21:38:11.000Z","date":"2021-03-01","kind":"tax_withholding","acquired":false,"shares":6244,"price":24.43,"value":152540.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents 6,244 shares withheld for payment of taxes upon vesting of shares previously reported."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 182 shares acquired by Reporting person through Issuer's Employee Stock Purchase Plan since the last Form 4 filing."}],"balance_after":124800,"source":{"system":"sec-edgar","filing":"0001209191-21-016887","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/893949/000120919121016887/doc4.xml","form_type":"4"}},{"id":2816426,"issuer":{"id":4451,"kind":"organization","name":"Pediatrix Medical Group, Inc.","symbol":"MD"},"owners":[{"id":129660,"kind":"person","name":"Hinson Roger Mack","position":1,"cik":"0001826596","reported_name":"Hinson Roger Mack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres., PDX & OBX Medical Group"}}],"security":"Common Stock","published_at":"2021-03-03T21:38:11.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":30613,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Restricted shares granted pursuant to the Issuer's  Plan, in connection with an annual equity award.  Twenty-five percent (25%) of the restricted shares will vest on March 1, 2022, twenty-five percent (25%) of the restricted shares will vest on March 1, 2023 and fifty percent (50%) of the restricted shares will vest on March 1, 2024."}],"balance_after":130862,"source":{"system":"sec-edgar","filing":"0001209191-21-016887","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/893949/000120919121016887/doc4.xml","form_type":"4"}},{"id":2816425,"issuer":{"id":4451,"kind":"organization","name":"Pediatrix Medical Group, Inc.","symbol":"MD"},"owners":[{"id":129660,"kind":"person","name":"Hinson Roger Mack","position":1,"cik":"0001826596","reported_name":"Hinson Roger Mack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres., PDX & OBX Medical Group"}}],"security":"Common Stock","published_at":"2021-03-03T21:38:11.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":30612,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan (the \"Plan\"), in connection with an annual equity award.  The number of shares being reported represents the \"target\" number of restricted shares and does not include the right of the reporting person to receive up to 15,306 additional shares based on the achievement of certain performance-based criteria for the twelve months ending December 31, 2021. The actual number of shares earned could be less than or greater than the target number, depending on the level of performance achieved, and all of the restricted shares granted are subject to forfeiture if minimum levels of performance are not met.  Any restricted shares earned will not vest any earlier than in three installments of twenty-five (25%) on March 1, 2022, twenty-five (25%) on March 1, 2023 and  fifty (50%) on March 1, 2024, subject to the terms of the Plan."}],"balance_after":100249,"source":{"system":"sec-edgar","filing":"0001209191-21-016887","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/893949/000120919121016887/doc4.xml","form_type":"4"}}]}